Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Dalia El-Shourbagy"'
Autor:
Muhammad Latif, Elamin Abdelgadir, Mohamed Omara, Fauzia Rashid, Syed Tirmazy, Faraz Khan, Maroun El Khoury, Alaaeldin Bashier, Fatheya Alawadi, Kaltar Das, Susheel Kumar, Abdul Basit, Dalia El-Shourbagy, Dina Hamza, Faisal Azam
Publikováno v:
Middle East Journal of Cancer, Vol 13, Iss 4, Pp 616-623 (2022)
Background: Immune checkpoint inhibitors (ICIs), including antiprogrammed cell death receptor-1, antiprogrammed cell death ligand-1, and anticytotoxic T-lymphocyte-antigen 4, have improved patients’ outcome in advanced malignancies. These agents ar
Externí odkaz:
https://doaj.org/article/9063cb211c5e4780916e90690ca89aae
Autor:
Muhammad Latif, Syed Tirmazy, Dalia El-Shourbagy, Abdul Basit, Kaltar Das, Mohamed Omara, Dina Hamza, Susheel Kumar, Nezar Ahmed Salim, Shila Sajan
Publikováno v:
Middle East Journal of Cancer, Vol 13, Iss 4, Pp 733-735 (2022)
Externí odkaz:
https://doaj.org/article/e0c52861001b4759aebf577ab55e9a1a
Autor:
Ahmed Mohieldin, Hassan Jaafar, Dalia El Shourbagy, Aladdin Maarraou, Muath Al-Nassar, Trad Diaeddine, Abdulaziz Al Farsi, Emad Anwar Dawoud, Reyad Mohsen
Publikováno v:
Journal of Cancer Prevention & Current Research. 11:130-134
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a182369afcba805eaff280b4372cb2d
https://doi.org/10.15406/jcpcr.2020.11.00440
https://doi.org/10.15406/jcpcr.2020.11.00440
Autor:
Mohamed Abouagour, Ehab Abdou, Enrique Grande, Emad Dawoud, Abdul R Zar, Humaid O. Al-Shamsi, Dalia El-Shourbagy, Ravi M Pedapenki
Publikováno v:
Expert Review of Anticancer Therapy. 20:831-840
The approval of combination treatments for metastatic renal cell carcinoma (mRCC) represents a major change in the clinical management of this malignancy. Updated treatment guidelines differentiate first-line mRCC treatment by patient risk group as d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d0c8bbf1650ab7e02ade2977844b2c34
https://doi.org/10.1080/14737140.2020.1810572
https://doi.org/10.1080/14737140.2020.1810572
Autor:
A. Gabsi, Syed A. Hussain, Syed Hammad Tirmazy, A. Basit, A. Alwbari, A. Alshangiti, Humaid O. Al-Shamsi, Muhammad Farooq Latif, K. Das, Faisal Azam, Dalia El-Shourbagy, Dina Hamza, Mohamed Omara, S. Kumar, Nedal Bukhari, M. M. Atef, W. M. Al Selwi, F. Ibnshamsah, Shahid Bashir
Publikováno v:
Journal of Clinical Oncology. 39:e24105-e24105
e24105 Background: Cancer care has been severely affected by covid 19 pandemic leading to medical, ethical and organizational issues. Oncology healthcare professionals face challenges due to reorganization of cancer services and increasing health car
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::af725206b8e5346a7d71adaa2aaa431a
https://doi.org/10.1200/jco.2021.39.15_suppl.e24105
https://doi.org/10.1200/jco.2021.39.15_suppl.e24105